605 related articles for article (PubMed ID: 21377506)
1. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
[TBL] [Abstract][Full Text] [Related]
5. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
6. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
[TBL] [Abstract][Full Text] [Related]
7. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
[TBL] [Abstract][Full Text] [Related]
9. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
Kang HJ; Park HJ
Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
Zhang Z; He X; Yuan G
Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
[TBL] [Abstract][Full Text] [Related]
11. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene.
Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Eur J Med Chem; 2011 May; 46(5):1906-13. PubMed ID: 21392861
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
13. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.
Siddiqui-Jain A; Grand CL; Bearss DJ; Hurley LH
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11593-8. PubMed ID: 12195017
[TBL] [Abstract][Full Text] [Related]
15. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription.
Agarwal T; Roy S; Chakraborty TK; Maiti S
Bioorg Med Chem Lett; 2010 Aug; 20(15):4346-9. PubMed ID: 20615700
[TBL] [Abstract][Full Text] [Related]
16. 4-(1H-imidazo[4,5-f]-1,10-phenanthrolin-2-yl)phenol-based G-quadruplex DNA binding agents: telomerase inhibition, cytotoxicity and DNA-binding studies.
Wei CY; Wang JH; Wen Y; Liu J; Wang LH
Bioorg Med Chem; 2013 Jun; 21(11):3379-87. PubMed ID: 23611765
[TBL] [Abstract][Full Text] [Related]
17. C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization.
Lavrado J; Reszka AP; Moreira R; Neidle S; Paulo A
Bioorg Med Chem Lett; 2010 Dec; 20(23):7042-5. PubMed ID: 20952194
[TBL] [Abstract][Full Text] [Related]
18. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
Yin F; Liu J; Deng X; Wang J
J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
[TBL] [Abstract][Full Text] [Related]
19. Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression.
Agarwal T; Roy S; Chakraborty TK; Maiti S
Biochemistry; 2010 Sep; 49(38):8388-97. PubMed ID: 20712380
[TBL] [Abstract][Full Text] [Related]
20. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.
Peng D; Tan JH; Chen SB; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2010 Dec; 18(23):8235-42. PubMed ID: 21036049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
